Concert Pharmaceuticals Inc. (CNCE) Dropped -5.08% or -0.96 To Price $17.95 On Thursday


Concert Pharmaceuticals Inc. (CNCE) dropped -5.08% or -0.96 to $17.95. It is approximately 207140 shares traded, which is 136.05% compare to the average total volume 152253. The market cap of CNCE is $419.95 million. The year to date change is -538.25%. The 52 week price range is from $12.67 to $30.71. Price of CNCE have changed -7.44% during last week. It have changed -3.52% over last month, -13.49% over last 3 months, -20.11% over last 6 months and 46.48% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCE is 19.77. It is 10.14% above current price. The 200-day Moving Averages for CNCE is 19.83. It is 10.47% above current price. The 52-week High is 30.71. It is 71.09% from the current price. The 52-week Low is 12.67. It is -29.42% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNCE is 4.51 on 2018-05-15. Short % to float is 3.44%. There are some statistics of CNCE. It is has market cap $419.95 million. The share outstanding is 23.40 million. The average volume is 152253. The revenue is 143.86M. The percent of top 15 Institution holding is 56.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCE is 70.33%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCE is 63.21%.


Tags:

Share this post